Abstract
BackgroundThalidomide is a chemotherapeutic agent approved by the EMA for multiple myeloma treatment. It is considered a high risk drug and should be prescribed and dispensed within a special pharmacovigilance...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have